|Comvita Limited -- USA Stock|| |
USD 5.99 0.00 0.00%
Non-Executive Deputy Chairman of the Board
Mr. Alan John Bougen is no longer a NonExecutive Deputy Chairman of the Board of Comvita Limited., effective October 2017. He having been a foundation Director since 1976 and serving as Managing Director until 1998. His background in the natural healthcare industry, apiculture and international marketing, brings a particularly pertinent industry and global perspective to the Board as Comvita continues in the developments of its key offshore markets. Alan is a member of the Institute of Directors and operates his own consultancy business which includes directorships in other private companies.
64 7 533 1426 http://www.comvita.co.nz
The company has return on total asset (ROA)
of 0.25 %
which means that it generated profit of $0.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 6.64 %
meaning that it generated $6.64 on every $100 dollars invested by stockholders.
The company has accumulated 63.4 M in total debt with debt to equity ratio (D/E) of 46.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Comvita Limited has Current Ratio of 7.87 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Comvita Limited manufactures and markets natural health products. Comvita Limited was founded in 1974 and is headquartered in Te Puke, New Zealand. Comvita Limited operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market.Comvita Limited (CVNZF) is traded on OTC Market in USA. It is located in 23 Wilson Road South and employs 500 people.
Comvita Limited Leadership Team
|Sarah Ottrey, Director|
|Simon Pothecary, Executive|
|Ben Shaw, Executive|
|Paul Reid, Director|
|Roy Ong, Executive|
|Patrick Brus, Executive|
|Alan Bougen, Chairman|
|Maurice Prendergast, Director|
|Scott Coulter, CEO|
|Lucas Bunt, Director|
|Murray Denyer, Director|
|Sharon Hollenstein, Executive|
|Brett Hewlett, CEO|
|Julianne Keast, CFO|
|Mark Sadd, Executive|
|Thomas Cullwick, Director|
|Neil Craig, Chairman|
|Kate Selway, Executive|
|Edward Quilty, Director|
|RalfChristian Schlothauer, Executive|
|MBA DipT, Executive|
|Sarah Kennedy, Director|
|Colin Baskin, Executive|
|Julie Chadwick, Executive|
Stock Performance Indicators
Macroaxis portfolio users are unresponsive in their opinion about investing in Comvita Limited. What is your opinion about investing in Comvita Limited? Are you bullish or bearish?
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1)
For any level of risk, select the one which has the highest expected return. 2)
For any expected return, select the one which has the lowest volatility.